Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$11,035,955
+$2,869,319 QoQ
Shares Held
9,201
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.51%
of 13F equity value
Holder Rank
#1,206
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PLIMOTH TRUST CO LLC holds $39,896,675 across 10 Drug Manufacturers - General names. LLY ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,201 | $11,035,955 | |
| 2 | MRK |
Merck & Co., Inc.
|
63,317 | $8,136,234 | |
| 3 | JNJ |
Johnson & Johnson
|
30,772 | $7,815,164 | |
| 4 | ABBV |
AbbVie Inc.
|
18,365 | $4,621,367 | |
| 5 | AMGN |
Amgen Inc
|
11,650 | $4,218,697 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,547 | $1,414,398 | |
| 7 | PFE |
Pfizer Inc
|
49,223 | $1,185,289 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,575 | $830,685 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,035,955 | 9,201 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,166,636 | 8,879 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,088,569 | 8,457 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $6,486,263 | 8,501 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $6,376,555 | 8,180 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $6,452,833 | 7,813 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $4,069,212 | 5,271 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,630,807 | 5,227 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $5,740,108 | 6,340 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,109,640 | 6,568 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $4,110,751 | 7,052 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,900,637 | 7,262 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,641,159 | 7,764 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,712,674 | 7,899 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,975,010 | 8,132 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,978,376 | 9,211 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $2,978,051 | 9,185 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,900,355 | 10,128 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,899,204 | 10,496 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $2,478,242 | 10,726 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $2,586,919 | 11,271 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $2,154,781 | 11,534 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,971,882 | 11,679 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $2,101,735 | 14,199 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,259,280 | 13,761 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,037,934 | 14,691 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||